Tech Company Financing Transactions

CeraPedics Funding Round

CeraPedics closed a $19 million Series C funding round on 12/12/2012. Backers included CVF, MedImmune Ventures and NGN Capital.

Transaction Overview

Company Name
Announced On
12/12/2012
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series C
Proceeds Purpose
Proceeds will be used to support the company's ongoing activities with its current Investigational Device Exemption (IDE) clinical trial in the United States studying its i-FACTOR(TM) peptide enhanced bone graft for cervical spine applications and prepare for commercialization upon FDA approval.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11025 Dover St. 1600
Westminster, CO 80021
USA
Email Address
Overview
At Cerapedics, we are focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology (P-15) on anorganic bone mineral (ABM), supported by the highest level of clinical evidence, and validated in clinically relevant real world applications.
Profile
CeraPedics LinkedIn Company Profile
Social Media
CeraPedics Company Twitter Account
Company News
CeraPedics News
Facebook
CeraPedics on Facebook
YouTube
CeraPedics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Glen Kashuba
  Glen Kashuba LinkedIn Profile  Glen Kashuba Twitter Account  Glen Kashuba News  Glen Kashuba on Facebook
Chief Financial Officer
Drew Trivisonno
  Drew Trivisonno LinkedIn Profile  Drew Trivisonno Twitter Account  Drew Trivisonno News  Drew Trivisonno on Facebook
Chief Operating Officer
Jeff Marx
  Jeff Marx LinkedIn Profile  Jeff Marx Twitter Account  Jeff Marx News  Jeff Marx on Facebook
VP - Bus. Development
Andrew Woods
  Andrew Woods LinkedIn Profile  Andrew Woods Twitter Account  Andrew Woods News  Andrew Woods on Facebook
VP - Marketing
Scott Johnson
  Scott Johnson LinkedIn Profile  Scott Johnson Twitter Account  Scott Johnson News  Scott Johnson on Facebook
VP - R & D
Jerome Connor
  Jerome Connor LinkedIn Profile  Jerome Connor Twitter Account  Jerome Connor News  Jerome Connor on Facebook
VP - Regulatory Affairs
Roger White
  Roger White LinkedIn Profile  Roger White Twitter Account  Roger White News  Roger White on Facebook
VP - Sales
Andrew Barnes
  Andrew Barnes LinkedIn Profile  Andrew Barnes Twitter Account  Andrew Barnes News  Andrew Barnes on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/12/2012: Ensenda venture capital transaction
Next: 12/12/2012: MyEdGPS venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary